JP Morgan Chase
GSK icon

JP Morgan Chase’s GSK GSK Stock Holding History

JP Morgan Chase’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,000
Closed -$5.81M – 7312
2025
Q1 		$5.81M Sell
150,000
-630,000
-81% -$23.1M ﹤0.01% 3023
2024
Q4 		$26.4M Buy
+780,000
New +$28.1M ﹤0.01% 1783
2022
Q4 		– Sell
-400
Closed -$12K – 6728
2022
Q3 		$12K Buy
+400
New +$15.2K ﹤0.01% 5928
2022
Q1 		– Sell
-1,520
Closed -$84K – 6765
2021
Q4 		$84K Buy
+1,520
New +$79.1K ﹤0.01% 5753
2018
Q2 		– Sell
-10,320
Closed -$504K – 5587
2018
Q1 		$504K Sell
10,320
-105,680
-91% -$4.92M ﹤0.01% 4005
2017
Q4 		$5.14M Hold
116,000
– – ﹤0.01% 2655
2017
Q3 		$5.86M Buy
+116,000
New +$5.89M ﹤0.01% 2440
2017
Q2 		– Sell
-116,000
Closed -$6.11M – 5056
2017
Q1 		$6.11M Sell
116,000
-25,280
-18% -$1.28M ﹤0.01% 2294
2016
Q4 		$6.8M Buy
141,280
+25,280
+22% +$1.25M ﹤0.01% 2206
2016
Q3 		$6.25M Sell
116,000
-5,440
-4% -$298K ﹤0.01% 2092
2016
Q2 		$6.58M Buy
121,440
+5,440
+5% +$287K ﹤0.01% 2108
2016
Q1 		$5.88M Buy
116,000
+114,560
+7,956% +$5.71M ﹤0.01% 2118
2015
Q4 		$73K Hold
1,440
– – ﹤0.01% 3838
2015
Q3 		$69K Hold
1,440
– – ﹤0.01% 3774
2015
Q2 		$75K Sell
1,440
-4,160
-74% -$234K ﹤0.01% 3898
2015
Q1 		$323K Buy
5,600
+439
+9% +$25.2K ﹤0.01% 3678
2014
Q4 		$276K Buy
+5,161
New +$289K ﹤0.01% 3904
2014
Q1 		– Sell
-480
Closed -$32K – 3713
2013
Q4 		$32K Hold
480
– – ﹤0.01% 3993
2013
Q3 		$30K Hold
480
– – ﹤0.01% 4294
2013
Q2 		$30K Buy
+480
New +$30.5K ﹤0.01% 4310

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase's GSK Position: Q1 2026 in Review

JP Morgan Chase reduced its GSK (GSK) stake by 75% in Q1 2026, selling an estimated $92.3M and leaving 578,828 shares worth $31.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

JP Morgan Chase first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $536M in Q3 2015. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • JP Morgan Chase held 578,828 shares of GSK worth $31.4M as of Q1 2026.
  • JP Morgan Chase sold 1,702,989 GSK shares in Q1 2026, an estimated $92.3M.
  • GSK made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1703 holding.
  • JP Morgan Chase first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's GSK position peaked at $536M in Q3 2015.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.